INTERNATIONAL PATENT: SHANGHAI BAO PHARMACEUTICALS CO., LTD., 上海宝济药业股份有限公司 FILES APPLICATION FOR "MUTANT OF IMMUNOGLOBULIN-DEGRADING ENZYME IDEE"

GENEVA, May 26 -- SHANGHAI BAO PHARMACEUTICALS CO., LTD. (No.28, Luoxin RoadBaoshan District, Shanghai 201908), 上海宝济药业股份有限公司 (中国上海市宝山区罗新路28号) filed a patent application (PCT/CN2024/130963) for "MUTANT OF IMMUNOGLOBULIN-DEGRADING ENZYME IDEE" on Nov 08, 2024. With publication no. WO/2025/103235, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Zheng (No...